Results revealed altered hepatic HNF-1α expression, thereby identifying HNF-1α as a promising molecular target for the development of future therapies aimed at preventing liver dysfunction and, consequently, may open new avenues for ameliorating diabetes and related severe metabolic conditions. Here, HNF1A is linked to diabetes mellitus.